Powered Prosthetics for Knee Amputations
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how powered prosthetics can improve walking for individuals with above-knee amputations. Researchers aim to determine if adding power to the knee, the ankle, or both can enhance walking ease and efficiency. Participants will test various prosthetic combinations, including the SRALab Hybrid Knee and SRALab Polycentric Powered Ankle, and receive training to identify the most effective option. Ideal candidates have a transfemoral amputation (above the knee), have used a prosthetic leg for at least six months, and can walk 50 meters unaided.
As an unphased trial, this study allows participants to contribute to innovative research that could enhance mobility for many.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. Please consult with the study team or your doctor for guidance.
What prior data suggests that these powered prosthetics are safe for transfemoral amputees?
Research has shown that powered prosthetic devices, such as the SRALab Hybrid Knee and SRALab Polycentric Powered Ankle, are generally easy for users to handle. In studies where participants tried these devices, researchers found no major safety issues. For instance, one study with a 70-year-old man who had a leg amputation demonstrated that he could use these devices effectively after some training. This suggests they can be safe and manageable with proper guidance.
These devices are part of research aimed at improving walking for people with above-knee amputations. They are not yet approved for widespread use, so researchers continue to closely monitor safety. While some minor discomfort or adjustment issues might occur, major problems are not commonly reported.12345Why are researchers excited about this trial?
Researchers are excited about the SRALab Hybrid Knee and SRALab Polycentric Powered Ankle because these devices offer dynamic, powered support that closely mimics natural leg movement, unlike current prosthetic options like the Ottobock C-Leg, which primarily offer passive support. The Hybrid Knee's advanced microprocessor technology adjusts in real-time to the user's movement, providing smoother transitions and more natural walking patterns. Meanwhile, the Polycentric Powered Ankle enhances stability and adaptability across various terrains, potentially improving balance and reducing the effort required for walking. These innovations aim to empower users with greater mobility and independence, sparking hope for a significant leap in quality of life for those with knee amputations.
What evidence suggests that these prosthetic devices are effective for improving ambulation in knee amputees?
This trial will evaluate the effectiveness of powered prosthetics, such as the SRALab Hybrid Knee and SRALab Polycentric Powered Ankle, for individuals with knee amputations. Research has shown that these powered prosthetics can greatly improve walking compared to non-powered prosthetics. Participants will be assigned to different arms, receiving either the SRALab devices or other prosthetic combinations like the Ottobock Cleg4 and foot. These devices add strength to the missing joints, helping users walk more naturally and efficiently. Early results suggest that powering both the knee and ankle might further boost walking ability. With focused training on these powered devices, users may experience even greater improvements, leading to better mobility in everyday life.13567
Are You a Good Fit for This Trial?
This trial is for K2-level transfemoral amputees, meaning individuals who have had an above-knee amputation and can walk with a cane or crutches. The study aims to understand the impact of powered prosthetic knees and ankles on their walking ability.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Baseline data collection with Ottobock Cleg 4/Ottobock foot or clinically prescribed microprocessor knee unit/foot
Condition A: CLeg + Polycentric Ankle
Participants are fit with the CLeg + Polycentric Ankle and undergo device tuning and functional outcome assessments
Condition B: SRALab Hybrid Knee + Passive Ankle
Participants switch to SRALab Hybrid Knee + Passive Ankle and repeat the protocol for device tuning and assessments
Intensive Training
Participants receive intensive clinical training with the SRALab Hybrid Knee + Polycentric Ankle
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- SRALab Hybrid Knee and SRALab Polycentric Powered Ankle
SRALab Hybrid Knee and SRALab Polycentric Powered Ankle is already approved in United States for the following indications:
- Transfemoral amputation for K2 level ambulators
Find a Clinic Near You
Who Is Running the Clinical Trial?
Shirley Ryan AbilityLab
Lead Sponsor